Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01): an open-label, phase 3 trial - Sun, J M; Lee, K H; Kim, S W (Cancer, 2012)
et al.